Table 2.
Metabolites | Fold Change * | ||||||
---|---|---|---|---|---|---|---|
B/A | C/B | D/B | E/B | F/B | G/B | H/B | |
Lactic Acid | 2.30 * | 0.095 * | 0.29 * | 0.63 | 0.79 | 0.46 * | 0.80 |
Oxalic Acid | 1.026 | 0.15 * | 1.93 | 0.42 | 0.93 | 0.52 | 1.15 |
Pyroglutamic Acid | 3.06 * | 16.36 * | 0.33 * | 0.117 * | 0.38 * | 0.45 * | 0.33 * |
D-Fructose | 2.52* | 0.19 * | 0.94 | 0.84 | 0.98 | 0.85 | 1.01 |
D- Sorbitol | 5.77 * | 1.027 | 0.89 | 0.64 | 2.46 * | 1.47 | 3.42 * |
D-Fructose | 21.32 * | 0.018 * | 0.11 * | 0.17 * | 0.76 | 0.31 * | 0.48 |
Arachidonic Acid | 0.25 * | 7.51 * | 3.91 * | 2.38 | 1.44 | 1.40 | 1.70 |
Oleamide | 0.051 * | 16.84 * | 17.53 | 31.53 * | 12.66 * | 31.47 * | 14.31 |
Erucylamide | 0.23 * | 15.90 * | 1.99 * | 0.92 | 0.73 | 0.77 | 1.49 |
Statistical comparisons equal the non-parametric Mann-Whitney test was performed. Results were considered only significant if p ≤ 0.05 using Kruskal-Wallis test analysis. Sample codes are presented as follows: (A) negative control, (B) positive control, (C) dexamethasone standard, (D) nano-Ag, (E) ASBE, (F) ASBE plus nano-Ag, (G) ASB nano-extract, and (H) ASB nano extract plus nano-Ag. * Denotes metabolites showing significant difference among treated groups.